Cingulate Inc.
CING- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001862150
No open-market purchases or sales by Cingulate Inc. insiders were filed in the last 90 days; 32 institutions reported holding it in 13F filings for Q2 2026, worth $9.88M in total; no superinvestor holds it.
Other share classesCINGW
Q4 2023 vs. Q3 2023
How the institutions holding Cingulate Inc. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Q4 2023 | Change |
|---|---|---|---|
| Holders | 20 | 5 | −15 |
| Shares | 1.36M | 3.81K | −1.36M (−99.7%) |
| Value | $964.5K | $29.1K | −$935.4K (−97.0%) |
New holders (1)
Institutions that held Cingulate Inc. at the end of Q4 2023 but not at the end of Q3 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Bank of America Corp | 2,616 | $20.0K | 0.00% |
Sold out (16)
Institutions that held Cingulate Inc. at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Armistice Capital, LLC | 754,792 | $535.1K |
| Vanguard Group Inc | 123,016 | $87.2K |
| Commonwealth Equity Services, LLC | 100,771 | $71.0K |
| Geode Capital Management, LLC | 55,795 | $39.6K |
| MML Investors Services, LLC | 50,000 | $35.0K |
| Prime Capital Investment Advisors, LLC | 48,262 | $34.2K |
| State Street Corp | 44,760 | $31.7K |
| HighTower Advisors, LLC | 34,425 | $24.0K |
| Envestnet Asset Management Inc | 31,369 | $22.2K |
| Mercer Global Advisors Inc | 31,369 | $22.0K |
| Avantax Advisory Services, Inc. | 28,408 | $20.1K |
| Sterneck Capital Management, LLC | 14,144 | $10.0K |
| KC Investment Advisors, LLC | 11,900 | $8.44K |
| LPL Financial LLC | 10,933 | $7.75K |
| Creative Planning | 10,919 | $7.74K |
| UBS Group AG | 140 | $99 |